Literature DB >> 17519388

High T-cell response to human cytomegalovirus induces chemokine-mediated endothelial cell damage.

Cynthia A Bolovan-Fritts1, Rodney N Trout, Stephen A Spector.   

Abstract

Human cytomegalovirus (CMV) infection has been linked to inflammatory diseases that involve vascular endothelial damage, including vascular disease and chronic transplant rejection. We previously reported that the host CD4(+) T-cell response to CMV antigen presented by endothelial cells can produce interferon-gamma and tumor necrosis factor-alpha at levels sufficient to drive induction of fractalkine, a key marker of inflammation, in endothelial cells. In this work, we report that donors with high frequencies of antigen-specific T cells to CMV (high responders) induce higher levels of activation-associated chemokines such as fractalkine, RANTES (regulated on activation, normal T cell expressed and secreted), and macrophage inflammatory protein-1beta, together with cell-adhesion markers in endothelial cells compared with donors with low levels of CMV-specific T cells (low responders). High-responder cultures had higher levels of leukocyte recruitment and adherence to the endothelial monolayers associated with progressive damage and loss of the endothelial cells. These processes that led to endothelial destruction only required viral antigen and did not require infectious virus. Our findings further support that CMV may represent one member of a class of persistent pathogens in which a high antigen-specific T-cell response defines an important risk factor for development of chronic inflammation and endothelial cell injury.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17519388      PMCID: PMC1976357          DOI: 10.1182/blood-2007-03-078881

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  31 in total

Review 1.  Scavenger receptors in innate immunity.

Authors:  Leanne Peiser; Subhankar Mukhopadhyay; Siamon Gordon
Journal:  Curr Opin Immunol       Date:  2002-02       Impact factor: 7.486

Review 2.  Innate immune recognition.

Authors:  Charles A Janeway; Ruslan Medzhitov
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

3.  Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy.

Authors:  Y F Zhou; M B Leon; M A Waclawiw; J J Popma; Z X Yu; T Finkel; S E Epstein
Journal:  N Engl J Med       Date:  1996-08-29       Impact factor: 91.245

4.  Fractalkine and vascular injury.

Authors:  H Umehara; E Bloom; T Okazaki; N Domae; T Imai
Journal:  Trends Immunol       Date:  2001-11       Impact factor: 16.687

5.  Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons.

Authors:  Giovanni Almanzar; Susanne Schwaiger; Brigitte Jenewein; Michael Keller; Dietmar Herndler-Brandstetter; Reinhard Würzner; Diether Schönitzer; Beatrix Grubeck-Loebenstein
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

6.  The safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapy.

Authors:  D A Wohl; M A Kendall; S Owens; G Holland; M Nokta; S A Spector; R Schrier; S Fiscus; M Davis; M A Jacobson; J S Currier; K Squires; B Alston-Smith; J Andersen; W R Freeman; M Higgins; F J Torriani
Journal:  HIV Clin Trials       Date:  2005 May-Jun

7.  CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation.

Authors:  Christian O Simon; Rafaela Holtappels; Hanna-Mari Tervo; Verena Böhm; Torsten Däubner; Silke A Oehrlein-Karpi; Birgit Kühnapfel; Angélique Renzaho; Dennis Strand; Jürgen Podlech; Matthias J Reddehase; Natascha K A Grzimek
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

8.  Cytomegalovirus infection of rats increases the neointimal response to vascular injury without consistent evidence of direct infection of the vascular wall.

Authors:  Y F Zhou; M Shou; E Guetta; R Guzman; E F Unger; Z X Yu; J Zhang; T Finkel; S E Epstein
Journal:  Circulation       Date:  1999-10-05       Impact factor: 29.690

9.  Role of fractalkine in leukocyte adhesion and migration and in vascular injury.

Authors:  H Umehara; T Imai
Journal:  Drug News Perspect       Date:  2001-10

10.  Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects.

Authors:  Andrew W Sylwester; Bridget L Mitchell; John B Edgar; Cara Taormina; Christian Pelte; Franziska Ruchti; Paul R Sleath; Kenneth H Grabstein; Nancy A Hosken; Florian Kern; Jay A Nelson; Louis J Picker
Journal:  J Exp Med       Date:  2005-09-05       Impact factor: 14.307

View more
  17 in total

Review 1.  Partners in Crime: The Role of CMV in Immune Dysregulation and Clinical Outcome During HIV Infection.

Authors:  Michael L Freeman; Michael M Lederman; Sara Gianella
Journal:  Curr HIV/AIDS Rep       Date:  2016-02       Impact factor: 5.071

2.  Relationship between functional ability in older people, immune system status, and intensity of response to CMV.

Authors:  Marco Antonio Moro-García; Rebeca Alonso-Arias; Antonio López-Vázquez; Francisco Manuel Suárez-García; Juan José Solano-Jaurrieta; José Baltar; Carlos López-Larrea
Journal:  Age (Dordr)       Date:  2011-04-13

3.  Productive Cytomegalovirus Infection Is Associated With Impaired Endothelial Function in ST-Elevation Myocardial Infarction.

Authors:  Anna Lebedeva; Elena Maryukhnich; Jean-Charles Grivel; Elena Vasilieva; Leonid Margolis; Alexander Shpektor
Journal:  Am J Med       Date:  2019-07-08       Impact factor: 4.965

4.  Cytomegalovirus-induced effector T cells cause endothelial cell damage.

Authors:  Pablo J E J van de Berg; Si-La Yong; Ester B M Remmerswaal; René A W van Lier; Ineke J M ten Berge
Journal:  Clin Vaccine Immunol       Date:  2012-03-07

5.  Clonal evolution of CD8+ T cell responses against latent viruses: relationship among phenotype, localization, and function.

Authors:  Ester B M Remmerswaal; Paul L Klarenbeek; Nuno L Alves; Marieke E Doorenspleet; Barbera D C van Schaik; Rebecca E E Esveldt; Mirza M Idu; Ester M M van Leeuwen; Nelly van der Bom-Baylon; Antoine H C van Kampen; Sven D Koch; Hanspeter Pircher; Frederike J Bemelman; Anja Ten Brinke; Frank Baas; Ineke J M Ten Berge; Rene A W van Lier; Niek de Vries
Journal:  J Virol       Date:  2014-10-22       Impact factor: 5.103

Review 6.  Cytomegalovirus reactivation in critically ill immunocompetent hosts: a decade of progress and remaining challenges.

Authors:  Charles H Cook; Joanne Trgovcich
Journal:  Antiviral Res       Date:  2011-03-23       Impact factor: 5.970

Review 7.  Cytomegalovirus and HIV: A Dangerous Pas de Deux.

Authors:  Sara Gianella; Scott Letendre
Journal:  J Infect Dis       Date:  2016-10-01       Impact factor: 5.226

8.  Endothelial damage from cytomegalovirus-specific host immune response can be prevented by targeted disruption of fractalkine-CX3CR1 interaction.

Authors:  Cynthia A Bolovan-Fritts; Stephen A Spector
Journal:  Blood       Date:  2007-09-25       Impact factor: 22.113

9.  Cytomegalovirus-infected human endothelial cells can stimulate allogeneic CD4+ memory T cells by releasing antigenic exosomes.

Authors:  Jason D Walker; Cheryl L Maier; Jordan S Pober
Journal:  J Immunol       Date:  2009-02-01       Impact factor: 5.422

10.  Senescent cytotoxic T cells in acute myocardial infarction: innocent bystanders or the horsemen of apocalypse?

Authors:  Jedrzej Hoffmann; Ioakim Spyridopoulos
Journal:  Cell Mol Immunol       Date:  2014-09-22       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.